ArticleSpinal cord2022

Safety and feasibility of autologous olfactory ensheathing cell and bone marrow mesenchymal stem cell co-transplantation in chronic human spinal cord injury: a clinical trial.

Homa Zamani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.